Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02327520
Other study ID # RP009
Secondary ID
Status Completed
Phase N/A
First received December 22, 2014
Last updated December 24, 2014
Start date January 2010
Est. completion date December 2014

Study information

Verified date December 2014
Source King Chulalongkorn Memorial Hospital
Contact n/a
Is FDA regulated No
Health authority Thailand: Ministry of Public Health
Study type Observational

Clinical Trial Summary

The authors retrieved in-patient medical data, including the expense, from the 2010 Thailand Nationwide Hospital Admission Database, which is part of the National Health Security Office (NHSO). The diagnosis of digestive diseases with any form of colitis listed in the causes, either as principal diagnosis or co-morbidity, coding by the ICD-10 was recorded. The inclusion criteria were: 1) diagnosis of enterocolitis due to Clostridium difficile (ICD10-A07); and 2) age of more than 18 years. If the data was incomplete, the case was excluded. The baseline characteristics, including age, sex, co-morbidity disease and history of endoscopy or surgery, were recorded. The burden of CDI was evaluated by length of hospital stay (LOS), mortality rate, and hospital charge.


Recruitment information / eligibility

Status Completed
Enrollment 204666
Est. completion date December 2014
Est. primary completion date December 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- The patients with the diagnosis of Clostridium difficile (ICD10-A07)

- Age of more than 18 years.

Exclusion Criteria:

- Data incompleted

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Intervention

Other:
Colitis with CDI treatment
All patients will be treated with standard treatment

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
King Chulalongkorn Memorial Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Death rate and length of hospital stay in CDI during admission Length of hospital stay(LOS), mortality rate and hospital charge were used as the indicators for evaluating the burden of CDI. participants will be followed for the duration of hospital stay, an expected average of 2 weeks No
Primary Hospital charge of CDI Length of hospital stay(LOS), mortality rate and hospital charge were used as the indicators for evaluating the burden of CDI. participants will be followed for the duration of hospital stay, an expected average of 2 weeks No
See also
  Status Clinical Trial Phase
Completed NCT02214771 - Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients N/A
Withdrawn NCT01552668 - Fidaxomicin to Prevent Clostridium Difficile Colonization Phase 4
Recruiting NCT03325855 - Fecal Microbiota Transplant National Registry
Not yet recruiting NCT03586206 - Relationship Between C. Difficile Toxins' Serum Level With C. Difficile Infection
Suspended NCT03350711 - A Screening and Recruitment Study in Adults Expressing Interest in the Emory Microbiota Enrichment Program
Withdrawn NCT03643887 - Phase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE Patients Phase 2
Terminated NCT04000555 - Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI) Phase 4
Terminated NCT03065374 - Treatment for Clostridium-difficile Infection With IMM529 Phase 1/Phase 2
Completed NCT03710694 - Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI) N/A
Completed NCT02865616 - MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI) Phase 1
Recruiting NCT04940468 - High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology N/A
Completed NCT02589847 - Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection Phase 2
Not yet recruiting NCT01942447 - Fecal Microbiota Transplantation in Recurrent or Refractory Clostridium Difficile Colitis N/A
Active, not recruiting NCT02086916 - Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection N/A
Completed NCT01230957 - Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults Phase 2
Completed NCT01241552 - A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001) Phase 3
Not yet recruiting NCT04567134 - Clostridioides Difficile Infection - a Prospective Nationwide Epidemiologic Study in Korea
Completed NCT04075422 - Bezlotoxumab - in "Real Life" - During the First Episode of Clostridium Difficile Infection in Patients With High Risk of Recurrence.
Recruiting NCT03712722 - Fecal Microbiota Transplantation (FMT) for Clostridium Difficile
Recruiting NCT05192148 - Seroprevalence of Antibodies to Surface Antigens and Toxins of Clostridioides Difficile N/A